Russell Frank Company’s Juno Therapeutics, Inc. JUNO Stock Holding History

Russell Frank Company’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$683K	Buy	17,919 +4,378	+32%	+$153K	﹤0.01%	2328
2015 Q4	$600K	Buy	13,541 +663	+5%	+$32.9K	﹤0.01%	2430
2015 Q3	$524K	Buy	12,878 +11,119	+632%	+$488K	﹤0.01%	2459
2015 Q2	$94K	Sell	1,759 -12,687	-88%	-$673K	﹤0.01%	2912
2015 Q1	$876K	Buy	14,446 +13,946	+2,789%	+$677K	﹤0.01%	2207
2014 Q4	$26K	Buy	+500	New	+$22.4K	﹤0.01%	2856

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Russell Frank Company's JUNO Position: Q1 2016 in Review

Russell Frank Company increased its Juno Therapeutics, Inc. (JUNO) stake by 32% in Q1 2016, buying an estimated $153K and bringing the position to 17,919 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Russell Frank Company first reported a position in JUNO in Q4 2014 and has held it in 6 quarters since. The position peaked at $876K in Q1 2015. 158 funds tracked by Wall St. Rank hold JUNO as of Q1 2016.

Russell Frank Company held 17,919 shares of Juno Therapeutics, Inc. worth $683K as of Q1 2016.
Russell Frank Company bought 4,378 Juno Therapeutics, Inc. shares in Q1 2016, an estimated $153K.
Juno Therapeutics, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2328 holding.
Russell Frank Company first reported a position in Juno Therapeutics, Inc. in Q4 2014 and has held it in 6 quarters since.
Russell Frank Company's Juno Therapeutics, Inc. position peaked at $876K in Q1 2015.
158 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.